Braveheart logo

Braveheart

Braveheart is a biopharmaceutical company developing BHB-1893, a selective small-molecule cardiac myosin inhibitor, aimed at transforming...

Facts

Sectors
Biopharmaceuticals, Pharmaceuticals, Cardiovascular therapeutics
Stage
Late-stage clinical development

Online